Recall events
/
Event 62511
Event summary
Timeline bucket July 09, 2012
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Lloyd Inc. of Iowa
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
12 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 12
Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
D-074-2013
Recall number D-074-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 1,923,887 tablets
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #HB01212
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5535]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 12
Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
D-075-2013
Recall number D-075-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 13,692/100-tablet bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #1097830 exp. 1/31/2013
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5589]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 12
Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
D-076-2013
Recall number D-076-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 3,826,269 tablets
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #HA31411 and #HE17811
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5542]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 12
Levothroid (levothyroxine sodium tablets, USP), 88 mcg., 100-count bottles, Rx only, NDC 0456-1329-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
D-077-2013
Recall number D-077-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 31,252/100-tablet bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #1096369, exp. 11/30/2012; and #1092046, exp. 7/31/2012
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8692]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 12
Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
D-078-2013
Recall number D-078-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 3,813,645 tablets
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #HC31411 and #HE18711
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7123]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 12
Levothroid (levothyroxine sodium tablets, USP), 112 mcg., 100-count bottles, Rx only, NDC 0456-1330-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
D-079-2013
Recall number D-079-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 37,827/100-tablet bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #1096371, exp. 5/312013; and #1092299, exp. 1/31/2013
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5523]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 12
Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
D-080-2013
Recall number D-080-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 1,924,174 tablets
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #HB27811
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5610]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 12
Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
D-081-2013
Recall number D-081-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 19,162/100-tablet bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #1095210, exp. 4/30/2013
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5577]
FDA event record
· Exact recall-number query on openFDA
drug · product 9 of 12
Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
D-082-2013
Recall number D-082-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 3,774,541 tablets
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #HA27911 and #HA12511
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5526]
FDA event record
· Exact recall-number query on openFDA
drug · product 10 of 12
Levothroid (levothyroxine sodium tablets, USP), 137 mcg., 100-count bottles, Rx only, NDC 0456-1331-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
D-083-2013
Recall number D-083-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 36,978/100-tablet bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #1095212 exp. 4/30/2013; and #1088877, exp. 11/30/2012
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5524]
FDA event record
· Exact recall-number query on openFDA
drug · product 11 of 12
Thyro-Tab 0.300 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
D-084-2013
Recall number D-084-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 1,902,957 tablets
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #HE35311
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5615]
FDA event record
· Exact recall-number query on openFDA
drug · product 12 of 12
Levothroid (levothyroxine sodium tablets, USP), 300 mcg., 100-count bottles, Rx only, NDC 0456-1328-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
D-085-2013
Recall number D-085-2013
Initiated July 09, 2012
Classification Class II
Status Terminated
Quantity 1,443/100-tablet bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations; does not meet in process specification requirements
Code information Lot #1097178 exp. 7/31/2013
Distribution pattern Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5583]
FDA event record
· Exact recall-number query on openFDA
